marketcaparena
Search

    IQV

    IQVIA HOLDINGS INC.

    Company overview

    Market capitalization
    $44.60B
    Employees
    93,000
    Latest publication
    2026-09-29
    About IQVIA HOLDINGS INC.

    IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Revenue4,368,000,000USD4,364,000,000USD4,100,000,000USD4,017,000,000USD3,829,000,000USD3,958,000,000USD3,896,000,000USD3,814,000,000USD
    Cost Of Revenue2,933,000,000USD4,072,000,000USD2,727,000,000USD2,694,000,000USD2,531,000,000USD2,580,000,000USD2,518,000,000USD2,757,000,000USD
    Gross Profit1,435,000,000USD292,000,000USD1,373,000,000USD1,323,000,000USD1,298,000,000USD1,378,000,000USD1,378,000,000USD1,057,000,000USD
    Selling General Administrative574,000,000USD468,000,000USD514,000,000USD509,000,000USD508,000,000USD453,000,000USD522,000,000USD509,000,000USD
    Total Operating Expenses929,000,000USD-440,000,000USD820,000,000USD817,000,000USD802,000,000USD752,000,000USD828,000,000USD509,000,000USD
    Operating Income506,000,000USD732,000,000USD553,000,000USD506,000,000USD496,000,000USD626,000,000USD550,000,000USD548,000,000USD
    Total Other Income Expense Net-205,000,000USD-160,000,000USD-145,000,000USD-183,000,000USD-186,000,000USD-77,000,000USD-201,000,000USD-110,000,000USD
    Interest Income7,000,000USD182,000,000USD13,000,000USD10,000,000USD11,000,000USD11,000,000USD13,000,000USD12,000,000USD
    Interest Expense197,000,000USD193,000,000USD189,000,000USD182,000,000USD165,000,000USD171,000,000USD170,000,000USD163,000,000USD
    Income Before Tax301,000,000USD572,000,000USD408,000,000USD323,000,000USD310,000,000USD549,000,000USD350,000,000USD438,000,000USD
    Income Tax Expense60,000,000USD58,000,000USD76,000,000USD57,000,000USD61,000,000USD112,000,000USD65,000,000USD75,000,000USD
    Equity Method Income Loss17,000,000USD———————
    Net Income258,000,000USD514,000,000USD331,000,000USD266,000,000USD249,000,000USD437,000,000USD285,000,000USD363,000,000USD
    Minority Interest2,000,000USD0USD-1,000,000USD—0USD———
    Net Income Applicable To Common Shares256,000,000USD514,000,000USD331,000,000USD266,000,000USD249,000,000USD437,000,000USD285,000,000USD—
    Unclassified Operating Expenses—-908,000,000USD306,000,000USD308,000,000USD294,000,000USD299,000,000USD306,000,000USD—
    Net Interest Income—-182,000,000USD-176,000,000USD-172,000,000USD-154,000,000USD-160,000,000USD-157,000,000USD-151,000,000USD
    Tax Provision—59,000,000USD76,000,000USD56,000,000USD61,000,000USD112,000,000USD65,000,000USD75,000,000USD
    Net Income From Continuing Ops—514,000,000USD332,000,000USD266,000,000USD249,000,000USD437,000,000USD285,000,000USD363,000,000USD
    Ebit—730,000,000USD597,000,000USD505,000,000USD488,000,000USD715,000,000USD519,000,000USD614,000,000USD
    Ebitda—1,047,000,000USD883,000,000USD781,000,000USD753,000,000USD1,018,000,000USD797,000,000USD883,000,000USD
    Depreciation And Amortization—317,000,000USD286,000,000USD276,000,000USD265,000,000USD303,000,000USD278,000,000USD269,000,000USD
    Reconciled Depreciation—317,000,000USD286,000,000USD276,000,000USD265,000,000USD303,000,000USD278,000,000USD269,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
    Total Revenue16,310,000,000USD15,405,000,000USD14,984,000,000USD14,410,000,000USD13,874,000,000USD5,737,000,000USD5,460,000,000USD5,099,545,000USD
    Cost Of Revenue12,024,000,000USD10,030,000,000USD9,745,000,000USD9,382,000,000USD9,233,000,000USD4,116,000,000USD3,959,000,000USD3,762,631,000USD
    Gross Profit4,286,000,000USD5,375,000,000USD5,239,000,000USD5,028,000,000USD4,641,000,000USD1,621,000,000USD1,501,000,000USD1,336,914,000USD
    Selling General Administrative1,999,000,000USD1,992,000,000USD2,053,000,000USD2,071,000,000USD1,964,000,000USD920,985,000USD882,338,000USD815,410,000USD
    Total Operating Expenses1,999,000,000USD3,173,000,000USD3,262,000,000USD3,229,000,000USD3,248,000,000USD975,000,000USD911,000,000USD874,581,000USD
    Operating Income2,287,000,000USD2,202,000,000USD1,977,000,000USD1,799,000,000USD1,393,000,000USD646,612,000USD590,390,000USD462,333,000USD
    Interest Income684,000,000USD47,000,000USD36,000,000USD403,000,000USD6,000,000USD97,475,000USD——
    Interest Expense729,000,000USD670,000,000USD672,000,000USD416,000,000USD375,000,000USD101,792,000USD100,589,000USD123,508,000USD
    Net Interest Income-684,000,000USD-623,000,000USD-636,000,000USD-403,000,000USD-369,000,000USD———
    Income Before Tax1,613,000,000USD1,669,000,000USD1,459,000,000USD1,351,000,000USD1,134,000,000USD547,000,000USD506,000,000USD323,116,000USD
    Income Tax Expense252,000,000USD296,000,000USD101,000,000USD260,000,000USD163,000,000USD158,989,000USD150,056,000USD95,965,000USD
    Tax Provision252,000,000USD301,000,000USD101,000,000USD260,000,000USD163,000,000USD158,989,000USD——
    Net Income1,360,000,000USD1,373,000,000USD1,358,000,000USD1,091,000,000USD966,000,000USD387,205,000USD356,383,000USD226,591,000USD
    Net Income From Continuing Ops1,361,000,000USD1,373,000,000USD1,358,000,000USD1,091,000,000USD971,000,000USD388,000,000USD352,133,000USD227,151,000USD
    Ebit2,320,000,000USD2,339,000,000USD2,131,000,000USD1,779,000,000USD1,503,000,000USD640,258,000USD601,987,000USD446,624,000USD
    Ebitda3,464,000,000USD3,453,000,000USD3,256,000,000USD2,909,000,000USD2,767,000,000USD768,000,000USD723,000,000USD554,128,000USD
    Depreciation And Amortization1,144,000,000USD1,114,000,000USD1,125,000,000USD1,130,000,000USD1,264,000,000USD127,742,000USD121,013,000USD107,504,000USD
    Reconciled Depreciation1,144,000,000USD1,114,000,000USD1,125,000,000USD1,130,000,000USD1,264,000,000USD———
    Total Other Income Expense Net-674,000,000USD-533,000,000USD-518,000,000USD-448,000,000USD-259,000,000USD-99,000,000USD-89,000,000USD-139,217,000USD
    Minority Interest-1,000,000USD0USD0USD0USD-5,000,000USD1,099,000USD118,000USD564,000USD
    Net Income Applicable To Common Shares1,360,000,000USD1,373,000,000USD1,358,000,000USD1,091,000,000USD966,000,000USD387,205,000USD356,383,000USD226,591,000USD
    Unclassified Operating Expenses—1,181,000,000USD1,209,000,000USD1,158,000,000USD1,284,000,000USD50,678,000USD23,682,000USD39,416,000USD
    Non Operating Income Net Other———-32,000,000USD116,000,000USD2,473,000USD16,756,000USD-16,833,000USD
    Research Development—————3,337,000USD4,980,000USD4,955,000USD
    Selling And Marketing Expenses———————14,800,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets29,881,000,000USD29,675,000,000USD29,944,000,000USD28,727,000,000USD28,632,000,000USD27,322,000,000USD26,899,000,000USD27,180,000,000USD
    Cash And Equivalents1,909,000,000USD—1,980,000,000USD1,814,000,000USD2,039,000,000USD1,740,000,000USD1,702,000,000USD1,572,000,000USD
    Cash And Short Term Investments2,080,000,000USD1,947,000,000USD2,141,000,000USD1,972,000,000USD2,188,000,000USD1,876,000,000USD1,843,000,000USD1,712,000,000USD
    Short Term Investments171,000,000USD156,000,000USD161,000,000USD158,000,000USD149,000,000USD136,000,000USD141,000,000USD140,000,000USD
    Total Current Assets6,226,000,000USD6,220,000,000USD6,249,000,000USD5,979,000,000USD6,345,000,000USD5,911,000,000USD5,829,000,000USD5,632,000,000USD
    Total Liabilities23,580,000,000USD———————
    Total Current Liabilities8,815,000,000USD8,329,000,000USD8,338,000,000USD8,508,000,000USD7,572,000,000USD7,179,000,000USD6,957,000,000USD6,992,000,000USD
    Other Current Liabilities457,000,000USD———————
    Other Non Current Liabilities645,000,000USD———————
    Total Stockholder Equity6,171,000,000USD6,221,000,000USD6,503,000,000USD6,160,000,000USD5,778,000,000USD5,977,000,000USD6,067,000,000USD6,967,000,000USD
    Total Equity Including Noncontrolling Interest6,301,000,000USD———————
    Short Long Term Debt4,588,000,000USD1,844,000,000USD1,840,000,000USD2,164,000,000USD1,313,000,000USD1,222,000,000USD1,145,000,000USD1,219,000,000USD
    Long Term Debt13,705,000,000USD13,989,000,000USD13,884,000,000USD12,793,000,000USD14,177,000,000USD13,108,000,000USD12,838,000,000USD12,293,000,000USD
    Deferred Revenue2,281,000,000USD———————
    Property Plant Equipment Net851,000,000USD809,000,000USD823,000,000USD824,000,000USD816,000,000USD768,000,000USD773,000,000USD772,000,000USD
    Goodwill16,604,000,000USD———————
    Intangible Assets4,749,000,000USD4,803,000,000USD4,962,000,000USD4,707,000,000USD4,596,000,000USD4,503,000,000USD4,499,000,000USD4,734,000,000USD
    Retained Earnings7,955,000,000USD7,699,000,000USD7,425,000,000USD6,911,000,000USD6,580,000,000USD6,314,000,000USD6,065,000,000USD5,628,000,000USD
    Accumulated Other Comprehensive Income-964,000,000USD-968,000,000USD-943,000,000USD-928,000,000USD-882,000,000USD-978,000,000USD-1,038,000,000USD-826,000,000USD
    Other Current Assets—352,000,000USD681,000,000USD693,000,000USD751,000,000USD724,000,000USD746,000,000USD670,000,000USD
    Total Liab—23,326,000,000USD23,314,000,000USD22,439,000,000USD22,846,000,000USD21,337,000,000USD20,832,000,000USD20,213,000,000USD
    Other Current Liab—413,000,000USD2,607,000,000USD515,000,000USD613,000,000USD319,000,000USD3,141,000,000USD354,000,000USD
    Common Stock—11,404,000,000USD11,378,000,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD
    Capital Stock—3,000,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD3,000,000USD
    Good Will—16,544,000,000USD16,616,000,000USD15,948,000,000USD15,611,000,000USD15,027,000,000USD14,710,000,000USD15,091,000,000USD
    Cash—1,947,000,000USD1,980,000,000USD1,814,000,000USD2,039,000,000USD1,740,000,000USD1,702,000,000USD1,572,000,000USD
    Current Deferred Revenue—2,261,000,000USD—2,160,000,000USD2,123,000,000USD1,940,000,000USD1,779,000,000USD1,824,000,000USD
    Net Debt—14,118,000,000USD14,194,000,000USD13,376,000,000USD13,661,000,000USD12,767,000,000USD12,454,000,000USD12,128,000,000USD
    Short Term Debt—1,844,000,000USD1,840,000,000USD2,164,000,000USD1,313,000,000USD1,222,000,000USD1,145,000,000USD1,219,000,000USD
    Short Long Term Debt Total—16,065,000,000USD16,174,000,000USD15,190,000,000USD15,700,000,000USD14,507,000,000USD14,156,000,000USD13,700,000,000USD
    Long Term Investments—452,000,000USD432,000,000USD405,000,000USD406,000,000USD383,000,000USD374,000,000USD320,000,000USD
    Net Receivables—3,921,000,000USD3,427,000,000USD3,314,000,000USD3,406,000,000USD3,311,000,000USD3,240,000,000USD3,250,000,000USD
    Accounts Payable—3,639,000,000USD3,751,000,000USD3,550,000,000USD3,399,000,000USD3,559,000,000USD736,000,000USD3,434,000,000USD
    Property Plant Equipment Gross—809,000,000USD1,728,000,000USD824,000,000USD816,000,000USD768,000,000USD1,592,000,000USD772,000,000USD
    Common Stock Shares Outstanding—169,800,000shares171,900,000shares171,700,000shares173,200,000shares177,400,000shares180,800,000shares184,200,000shares
    Non Current Assets Total—23,455,000,000USD23,695,000,000USD22,748,000,000USD22,287,000,000USD21,411,000,000USD21,070,000,000USD21,548,000,000USD
    Non Current Liabilities Total—14,997,000,000USD14,976,000,000USD13,931,000,000USD15,274,000,000USD14,158,000,000USD13,875,000,000USD13,221,000,000USD
    Non Current Liabilities Other—617,000,000USD688,000,000USD698,000,000USD671,000,000USD676,000,000USD668,000,000USD612,000,000USD
    Non Currrent Assets Other—846,000,000USD505,000,000USD474,000,000USD513,000,000USD485,000,000USD520,000,000USD467,000,000USD
    Net Working Capital—-2,109,000,000USD-2,089,000,000USD-2,529,000,000USD-1,227,000,000USD-1,268,000,000USD-1,128,000,000USD-1,360,000,000USD
    Unclassified Current Assets—-156,000,000USD—————-195,000,000USD
    Unclassified Current Liabilities—-1,672,000,000USD-1,700,000,000USD-2,045,000,000USD-1,189,000,000USD-1,083,000,000USD-989,000,000USD-1,058,000,000USD
    Unclassified Non Current Liabilities—391,000,000USD404,000,000USD440,000,000USD426,000,000USD374,000,000USD369,000,000USD316,000,000USD
    Unclassified Equity—-11,917,000,000USD-11,360,000,000USD171,000,000USD74,000,000USD635,000,000USD1,034,000,000USD2,159,000,000USD
    Other Assets——862,000,000USD864,000,000USD858,000,000USD730,000,000USD714,000,000USD631,000,000USD
    Unclassified Non Current Assets——-505,000,000USD-474,000,000USD-513,000,000USD-485,000,000USD-520,000,000USD-467,000,000USD
    Inventory———————195,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets29,944,000,000USD26,899,000,000USD26,681,000,000USD25,337,000,000USD24,689,000,000USD24,564,000,000USD23,251,000,000USD22,549,000,000USD
    Intangible Assets4,962,000,000USD4,499,000,000USD4,839,000,000USD4,820,000,000USD4,943,000,000USD5,205,000,000USD5,514,000,000USD5,951,000,000USD
    Other Current Assets681,000,000USD746,000,000USD687,000,000USD712,000,000USD677,000,000USD722,000,000USD589,000,000USD473,000,000USD
    Total Liab23,314,000,000USD20,832,000,000USD20,569,000,000USD19,572,000,000USD18,647,000,000USD18,284,000,000USD16,988,000,000USD15,595,000,000USD
    Total Stockholder Equity6,503,000,000USD6,067,000,000USD6,112,000,000USD5,765,000,000USD6,042,000,000USD6,001,000,000USD6,003,000,000USD6,714,000,000USD
    Other Current Liab629,000,000USD3,141,000,000USD3,149,000,000USD2,823,000,000USD2,567,000,000USD2,474,000,000USD211,000,000USD1,890,000,000USD
    Common Stock11,378,000,000USD3,000,000USD3,000,000USD10,898,000,000USD3,000,000USD3,000,000USD11,049,000,000USD10,901,000,000USD
    Capital Stock3,000,000USD3,000,000USD11,028,000,000USD10,898,000,000USD10,777,000,000USD11,095,000,000USD11,049,000,000USD10,901,000,000USD
    Retained Earnings7,425,000,000USD6,065,000,000USD4,692,000,000USD3,334,000,000USD2,243,000,000USD1,277,000,000USD998,000,000USD807,000,000USD
    Good Will16,616,000,000USD14,710,000,000USD14,567,000,000USD13,921,000,000USD13,301,000,000USD12,654,000,000USD12,159,000,000USD11,800,000,000USD
    Other Assets862,000,000USD714,000,000USD621,000,000USD590,000,000USD615,000,000USD1,133,000,000USD346,000,000USD344,000,000USD
    Cash1,980,000,000USD1,702,000,000USD1,376,000,000USD1,216,000,000USD1,366,000,000USD1,814,000,000USD837,000,000USD891,000,000USD
    Cash And Equivalents1,980,000,000USD1,702,000,000USD1,376,000,000USD1,216,000,000USD1,366,000,000USD1,814,000,000USD837,000,000USD891,000,000USD
    Cash And Short Term Investments2,141,000,000USD1,843,000,000USD1,496,000,000USD1,309,000,000USD1,477,000,000USD1,902,000,000USD899,000,000USD938,000,000USD
    Total Current Assets6,249,000,000USD5,829,000,000USD5,596,000,000USD4,981,000,000USD4,763,000,000USD5,090,000,000USD4,126,000,000USD3,874,000,000USD
    Total Current Liabilities8,338,000,000USD6,957,000,000USD6,491,000,000USD5,578,000,000USD5,241,000,000USD4,558,000,000USD3,945,000,000USD3,534,000,000USD
    Current Deferred Revenue2,118,000,000USD1,779,000,000USD1,799,000,000USD1,797,000,000USD1,825,000,000USD1,252,000,000USD1,014,000,000USD1,007,000,000USD
    Net Debt14,194,000,000USD12,454,000,000USD12,520,000,000USD11,795,000,000USD11,072,000,000USD11,090,000,000USD11,204,000,000USD10,116,000,000USD
    Short Term Debt1,840,000,000USD1,145,000,000USD718,000,000USD152,000,000USD91,000,000USD149,000,000USD100,000,000USD100,000,000USD
    Short Long Term Debt1,840,000,000USD1,145,000,000USD718,000,000USD152,000,000USD91,000,000USD149,000,000USD100,000,000USD100,000,000USD
    Short Long Term Debt Total16,174,000,000USD14,156,000,000USD13,896,000,000USD13,011,000,000USD12,438,000,000USD12,904,000,000USD12,041,000,000USD11,007,000,000USD
    Long Term Debt13,884,000,000USD12,838,000,000USD12,955,000,000USD12,595,000,000USD12,034,000,000USD12,384,000,000USD11,545,000,000USD10,907,000,000USD
    Long Term Investments432,000,000USD374,000,000USD239,000,000USD162,000,000USD164,000,000USD84,000,000USD87,000,000USD142,000,000USD
    Short Term Investments161,000,000USD141,000,000USD120,000,000USD93,000,000USD111,000,000USD88,000,000USD62,000,000USD47,000,000USD
    Net Receivables3,427,000,000USD3,240,000,000USD3,413,000,000USD2,960,000,000USD2,609,000,000USD2,466,000,000USD2,638,000,000USD2,463,000,000USD
    Accounts Payable3,751,000,000USD736,000,000USD709,000,000USD645,000,000USD621,000,000USD581,000,000USD2,512,000,000USD437,000,000USD
    Property Plant Equipment Net823,000,000USD773,000,000USD819,000,000USD863,000,000USD903,000,000USD953,000,000USD954,000,000USD434,000,000USD
    Property Plant Equipment Gross1,728,000,000USD1,592,000,000USD1,622,000,000USD863,000,000USD903,000,000USD953,000,000USD954,000,000USD434,000,000USD
    Accumulated Other Comprehensive Income-943,000,000USD-1,038,000,000USD-867,000,000USD-727,000,000USD-406,000,000USD-205,000,000USD-311,000,000USD-224,000,000USD
    Common Stock Shares Outstanding173,500,000shares183,400,000shares186,300,000shares190,600,000shares195,000,000shares195,000,000shares199,600,000shares208,200,000shares
    Non Current Assets Total23,695,000,000USD21,070,000,000USD21,085,000,000USD20,356,000,000USD19,926,000,000USD19,474,000,000USD19,125,000,000USD18,675,000,000USD
    Non Current Liabilities Total14,976,000,000USD13,875,000,000USD14,078,000,000USD13,994,000,000USD13,406,000,000USD13,726,000,000USD13,043,000,000USD12,061,000,000USD
    Non Current Liabilities Other688,000,000USD668,000,000USD698,000,000USD671,000,000USD649,000,000USD1,004,000,000USD852,000,000USD418,000,000USD
    Non Currrent Assets Other505,000,000USD520,000,000USD455,000,000USD472,000,000USD491,000,000USD386,000,000USD227,000,000USD239,000,000USD
    Net Working Capital-2,089,000,000USD-1,128,000,000USD-895,000,000USD-597,000,000USD-478,000,000USD532,000,000USD181,000,000USD340,000,000USD
    Unclassified Non Current Assets-505,000,000USD-520,000,000USD-455,000,000USD-472,000,000USD-491,000,000USD-941,000,000USD—-235,000,000USD
    Unclassified Current Liabilities-1,840,000,000USD-989,000,000USD-602,000,000USD——-47,000,000USD——
    Unclassified Non Current Liabilities404,000,000USD369,000,000USD425,000,000USD-647,000,000USD-746,000,000USD-971,000,000USD-1,072,000,000USD-1,140,000,000USD
    Unclassified Equity-11,360,000,000USD1,034,000,000USD-8,744,000,000USD-18,638,000,000USD——-11,049,000,000USD-10,901,000,000USD
    Deferred Long Term Liab———464,000,000USD410,000,000USD338,000,000USD646,000,000USD736,000,000USD
    Other Liab———911,000,000USD1,059,000,000USD971,000,000USD1,072,000,000USD1,140,000,000USD
    Inventory———151,000,000USD156,000,000USD159,000,000USD138,000,000USD151,000,000USD
    Net Tangible Assets———-12,976,000,000USD-12,202,000,000USD-11,858,000,000USD-11,670,000,000USD-11,037,000,000USD
    Unclassified Current Assets———-151,000,000USD-156,000,000USD-159,000,000USD-138,000,000USD-151,000,000USD
    Treasury Stock————-6,572,000,000USD-6,166,000,000USD-5,733,000,000USD-4,770,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation580,000,000USD
    Stock Based Compensation160,000,000USD
    Deferred Income Tax-74,000,000USD
    Other Non Cash Items-3,000,000USD
    Operating Cash Flow1,176,000,000USD
    Capital Expenditures-325,000,000USD
    Other Investing Activities-203,000,000USD
    Unclassified Investing Cash Flow-49,000,000USD
    Investing Cash Flow-577,000,000USD
    Net Debt Issuance1,758,000,000USD
    Net Common Stock Issuance-950,000,000USD
    Other Financing Activities-9,000,000USD
    Unclassified Financing Cash Flow-1,446,000,000USD
    Financing Cash Flow-647,000,000USD
    Effect Of Forex Changes On Cash-23,000,000USD
    Change In Cash-71,000,000USD
    End Cash Flow1,909,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income275,000,000USD514,000,000USD332,000,000USD266,000,000USD249,000,000USD437,000,000USD285,000,000USD363,000,000USD
    Depreciation288,000,000USD317,000,000USD286,000,000USD276,000,000USD265,000,000USD303,000,000USD278,000,000USD269,000,000USD
    Stock Based Compensation65,000,000USD60,000,000USD55,000,000USD60,000,000USD72,000,000USD48,000,000USD54,000,000USD48,000,000USD
    Other Non Cash Items18,000,000USD-54,000,000USD-171,000,000USD-10,000,000USD19,000,000USD7,000,000USD-13,000,000USD4,000,000USD
    Change To Account Receivables193,000,000USD-382,000,000USD173,000,000USD141,000,000USD128,000,000USD-77,000,000USD72,000,000USD122,000,000USD
    Change In Working Capital10,000,000USD-54,000,000USD452,000,000USD-104,000,000USD4,000,000USD105,000,000USD151,000,000USD-82,000,000USD
    Total Cash From Operating Activities618,000,000USD735,000,000USD908,000,000USD443,000,000USD568,000,000USD885,000,000USD721,000,000USD588,000,000USD
    Capital Expenditures-127,000,000USD-174,000,000USD293,000,000USD-151,000,000USD-142,000,000USD-164,000,000USD-150,000,000USD-143,000,000USD
    Free Cash Flow491,000,000USD561,000,000USD1,201,000,000USD292,000,000USD426,000,000USD721,000,000USD571,000,000USD445,000,000USD
    Investments1,000,000USD0USD-550,000,000USD-346,000,000USD-305,000,000USD-310,000,000USD-599,000,000USD-221,000,000USD
    Total Cashflows From Investing Activities-196,000,000USD-1,104,000,000USD-550,000,000USD-346,000,000USD-305,000,000USD-310,000,000USD-599,000,000USD-221,000,000USD
    Net Borrowings167,000,000USD763,000,000USD-536,000,000USD856,000,000USD164,000,000USD783,000,000USD66,000,000USD—
    Total Cash From Financing Activities-433,000,000USD535,000,000USD-572,000,000USD145,000,000USD-258,000,000USD-375,000,000USD-137,000,000USD-260,000,000USD
    Sale Purchase Of Stock-552,000,000USD-212,000,000USD1,032,000,000USD-657,000,000USD-375,000,000USD-1,150,000,000USD-200,000,000USD0USD
    Change In Cash-33,000,000USD166,000,000USD-225,000,000USD299,000,000USD38,000,000USD130,000,000USD27,000,000USD101,000,000USD
    Begin Period Cash Flow1,980,000,000USD1,814,000,000USD2,039,000,000USD1,740,000,000USD1,702,000,000USD1,572,000,000USD1,545,000,000USD1,444,000,000USD
    End Period Cash Flow1,947,000,000USD1,980,000,000USD1,814,000,000USD2,039,000,000USD1,740,000,000USD1,702,000,000USD1,572,000,000USD1,545,000,000USD
    Other Cashflows From Investing Activities2,000,000USD4,000,000USD-386,000,000USD2,000,000USD-1,000,000USD4,000,000USD-2,000,000USD25,000,000USD
    Other Cashflows From Financing Activities-44,000,000USD59,000,000USD-1,069,000,000USD-54,000,000USD-47,000,000USD-8,000,000USD-3,000,000USD-7,000,000USD
    Unclassified Operating Cash Flow-38,000,000USD-48,000,000USD-46,000,000USD-45,000,000USD-41,000,000USD-15,000,000USD-34,000,000USD-14,000,000USD
    Unclassified Investing Cash Flow-72,000,000USD-934,000,000USD93,000,000USD149,000,000USD143,000,000USD160,000,000USD152,000,000USD118,000,000USD
    Unclassified Financing Cash Flow—-75,000,000USD—————-253,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income1,361,000,000USD1,373,000,000USD1,358,000,000USD1,091,000,000USD966,000,000USD308,000,000USD227,000,000USD284,000,000USD
    Depreciation1,144,000,000USD1,114,000,000USD1,125,000,000USD1,130,000,000USD1,264,000,000USD1,287,000,000USD1,202,000,000USD1,141,000,000USD
    Stock Based Compensation247,000,000USD206,000,000USD217,000,000USD194,000,000USD170,000,000USD95,000,000USD146,000,000USD113,000,000USD
    Other Non Cash Items-43,000,000USD-6,000,000USD-2,000,000USD44,000,000USD-5,000,000USD-14,000,000USD-20,000,000USD-1,000,000USD
    Change To Account Receivables60,000,000USD182,000,000USD-388,000,000USD-421,000,000USD-138,000,000USD255,000,000USD-124,000,000USD-297,000,000USD
    Change In Working Capital125,000,000USD158,000,000USD-280,000,000USD-84,000,000USD680,000,000USD459,000,000USD19,000,000USD-106,000,000USD
    Total Cash From Operating Activities2,654,000,000USD2,716,000,000USD2,149,000,000USD2,260,000,000USD2,942,000,000USD1,959,000,000USD1,417,000,000USD1,254,000,000USD
    Capital Expenditures-603,000,000USD-602,000,000USD-649,000,000USD-674,000,000USD-640,000,000USD-616,000,000USD-582,000,000USD-459,000,000USD
    Free Cash Flow2,051,000,000USD2,114,000,000USD1,500,000,000USD1,586,000,000USD2,302,000,000USD1,343,000,000USD835,000,000USD795,000,000USD
    Investments-18,000,000USD-1,444,000,000USD-1,868,000,000USD-2,006,000,000USD-10,000,000USD-2,000,000USD-22,000,000USD-23,000,000USD
    Total Cashflows From Investing Activities-2,305,000,000USD-1,444,000,000USD-1,603,000,000USD-2,006,000,000USD-2,103,000,000USD-796,000,000USD-1,190,000,000USD-810,000,000USD
    Net Borrowings1,247,000,000USD553,000,000USD802,000,000USD936,000,000USD70,000,000USD309,000,000USD700,000,000USD993,000,000USD
    Total Cash From Financing Activities-150,000,000USD-878,000,000USD-382,000,000USD-329,000,000USD-1,235,000,000USD-217,000,000USD-276,000,000USD-452,000,000USD
    Sale Purchase Of Stock-1,244,000,000USD-1,350,000,000USD-992,000,000USD-1,168,000,000USD-406,000,000USD-447,000,000USD-949,000,000USD-1,405,000,000USD
    Change In Cash278,000,000USD326,000,000USD160,000,000USD-150,000,000USD-448,000,000USD977,000,000USD-54,000,000USD-68,000,000USD
    Begin Period Cash Flow1,702,000,000USD1,376,000,000USD1,216,000,000USD1,366,000,000USD1,814,000,000USD837,000,000USD891,000,000USD959,000,000USD
    End Period Cash Flow1,980,000,000USD1,702,000,000USD1,376,000,000USD1,216,000,000USD1,366,000,000USD1,814,000,000USD837,000,000USD891,000,000USD
    Other Cashflows From Investing Activities74,000,000USD2,000,000USD5,000,000USD8,000,000USD5,000,000USD-2,000,000USD27,000,000USD-457,000,000USD
    Other Cashflows From Financing Activities-44,000,000USD-81,000,000USD-192,000,000USD-102,000,000USD-899,000,000USD-112,000,000USD-74,000,000USD-62,000,000USD
    Unclassified Operating Cash Flow-180,000,000USD-129,000,000USD-269,000,000USD-115,000,000USD-133,000,000USD-176,000,000USD-157,000,000USD-177,000,000USD
    Unclassified Investing Cash Flow-1,758,000,000USD600,000,000USD909,000,000USD666,000,000USD-1,458,000,000USD-176,000,000USD-613,000,000USD129,000,000USD
    Unclassified Financing Cash Flow-109,000,000USD——5,000,000USD59,000,000USD77,000,000USD58,000,000USD4,098,000,000USD
    Change To Liabilities———299,000,000USD835,000,000USD170,000,000USD235,000,000USD250,000,000USD
    Cash And Cash Equivalents Changes———-75,000,000USD-396,000,000USD946,000,000USD-49,000,000USD-68,000,000USD
    Change To Inventory————-17,000,000USD-229,000,000USD-116,000,000USD-184,000,000USD
    Dividends Paid————-59,000,000USD-44,000,000USD-11,000,000USD-4,076,000,000USD
    Issuance Of Capital Stock———————15,000,000USD
    Exchange Rate Changes———————-60,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyAmericas2,039,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyAsia Pacific920,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyEMEA1,409,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentCommercial Solutions1,793,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentResearch And Development Solutions2,575,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyAmericas1,984,000,000USD0001628280-26-030675
    Q1 2026Quarterly · 2026-03-31GeographyAsia Pacific812,000,000USD0001628280-26-030675
    Q1 2026Quarterly · 2026-03-31GeographyEMEA1,355,000,000USD0001628280-26-030675
    Q1 2026Quarterly · 2026-03-31SegmentCommercial Solutions1,754,000,000USD0001628280-26-030675
    Q1 2026Quarterly · 2026-03-31SegmentResearch And Development Solutions2,397,000,000USD0001628280-26-030675
    Q4 2025Quarterly · 2025-12-31GeographyAmericas2,070,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyAsia Pacific871,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyEMEA1,423,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentContract Sales And Medical Solutions210,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentResearch And Development Solutions2,333,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentTechnology And Analytics Solutions1,821,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAmericas7,745,000,000USD0001628280-26-008322
    FY 2025Yearly · 2025-12-31GeographyAsia Pacific3,380,000,000USD0001628280-26-008322
    FY 2025Yearly · 2025-12-31GeographyEMEA5,185,000,000USD0001628280-26-008322
    FY 2025Yearly · 2025-12-31SegmentContract Sales And Medical Solutions788,000,000USD0001628280-26-008322
    FY 2025Yearly · 2025-12-31SegmentResearch And Development Solutions8,896,000,000USD0001628280-26-008322
    FY 2025Yearly · 2025-12-31SegmentTechnology And Analytics Solutions6,626,000,000USD0001628280-26-008322
    Q3 2025Quarterly · 2025-09-30GeographyAmericas1,933,000,000USD0001628280-25-046794
    Q3 2025Quarterly · 2025-09-30GeographyAsia Pacific870,000,000USD0001628280-25-046794
    Q3 2025Quarterly · 2025-09-30GeographyEMEA1,297,000,000USD0001628280-25-046794
    Q3 2025Quarterly · 2025-09-30SegmentContract Sales And Medical Solutions209,000,000USD0001628280-25-046794
    Q3 2025Quarterly · 2025-09-30SegmentResearch And Development Solutions2,260,000,000USD0001628280-25-046794
    Q3 2025Quarterly · 2025-09-30SegmentTechnology And Analytics Solutions1,631,000,000USD0001628280-25-046794
    Q2 2025Quarterly · 2025-06-30GeographyAmericas1,935,000,000USD0001478242-25-000106
    Q2 2025Quarterly · 2025-06-30GeographyAsia Pacific841,000,000USD0001478242-25-000106
    Q2 2025Quarterly · 2025-06-30GeographyEMEA1,241,000,000USD0001478242-25-000106
    Q2 2025Quarterly · 2025-06-30SegmentContract Sales And Medical Solutions188,000,000USD0001478242-25-000106
    Q2 2025Quarterly · 2025-06-30SegmentResearch And Development Solutions2,201,000,000USD0001478242-25-000106
    Q2 2025Quarterly · 2025-06-30SegmentTechnology And Analytics Solutions1,628,000,000USD0001478242-25-000106
    Q1 2025Quarterly · 2025-03-31GeographyAmericas1,807,000,000USD0001628280-26-030675
    Q1 2025Quarterly · 2025-03-31GeographyAsia Pacific798,000,000USD0001628280-26-030675
    Q1 2025Quarterly · 2025-03-31GeographyEMEA1,224,000,000USD0001628280-26-030675
    Q1 2025Quarterly · 2025-03-31SegmentContract Sales And Medical Solutions181,000,000USD0001478242-25-000087
    Q1 2025Quarterly · 2025-03-31SegmentResearch And Development Solutions2,102,000,000USD0001478242-25-000087
    Q1 2025Quarterly · 2025-03-31SegmentTechnology And Analytics Solutions1,546,000,000USD0001478242-25-000087
    Q4 2024Quarterly · 2024-12-31GeographyAmericas1,853,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyAsia Pacific807,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyEMEA1,298,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentContract Sales And Medical Solutions177,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentResearch And Development Solutions2,123,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentTechnology And Analytics Solutions1,658,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAmericas7,356,000,000USD0001628280-26-008322
    FY 2024Yearly · 2024-12-31GeographyAsia Pacific3,129,000,000USD0001628280-26-008322
    FY 2024Yearly · 2024-12-31GeographyEMEA4,920,000,000USD0001628280-26-008322
    FY 2024Yearly · 2024-12-31SegmentContract Sales And Medical Solutions718,000,000USD0001628280-26-008322
    FY 2024Yearly · 2024-12-31SegmentResearch And Development Solutions8,527,000,000USD0001628280-26-008322
    FY 2024Yearly · 2024-12-31SegmentTechnology And Analytics Solutions6,160,000,000USD0001628280-26-008322
    Q3 2024Quarterly · 2024-09-30GeographyAmericas1,838,000,000USD0001628280-25-046794
    Q3 2024Quarterly · 2024-09-30GeographyAsia Pacific771,000,000USD0001628280-25-046794
    Q3 2024Quarterly · 2024-09-30GeographyEMEA1,287,000,000USD0001628280-25-046794
    Q3 2024Quarterly · 2024-09-30SegmentContract Sales And Medical Solutions180,000,000USD0001628280-25-046794
    Q3 2024Quarterly · 2024-09-30SegmentResearch And Development Solutions2,162,000,000USD0001628280-25-046794
    Q3 2024Quarterly · 2024-09-30SegmentTechnology And Analytics Solutions1,554,000,000USD0001628280-25-046794
    FY 2023Yearly · 2023-12-31GeographyAmericas7,552,000,000USD0001628280-26-008322
    FY 2023Yearly · 2023-12-31GeographyAsia Pacific2,973,000,000USD0001628280-26-008322
    FY 2023Yearly · 2023-12-31GeographyEMEA4,459,000,000USD0001628280-26-008322
    FY 2023Yearly · 2023-12-31SegmentContract Sales And Medical Solutions727,000,000USD0001628280-26-008322
    FY 2023Yearly · 2023-12-31SegmentResearch And Development Solutions8,395,000,000USD0001628280-26-008322
    FY 2023Yearly · 2023-12-31SegmentTechnology And Analytics Solutions5,862,000,000USD0001628280-26-008322
    FY 2022Yearly · 2022-12-31GeographyAmericas7,048,000,000USD0001478242-25-000045
    FY 2022Yearly · 2022-12-31GeographyAsia Pacific2,996,000,000USD0001478242-25-000045
    FY 2022Yearly · 2022-12-31GeographyEMEA4,366,000,000USD0001478242-25-000045
    FY 2022Yearly · 2022-12-31SegmentContract Sales And Medical Solutions743,000,000USD0001478242-25-000045
    FY 2022Yearly · 2022-12-31SegmentResearch And Development Solutions7,921,000,000USD0001478242-25-000045
    FY 2022Yearly · 2022-12-31SegmentTechnology And Analytics Solutions5,746,000,000USD0001478242-25-000045
    FY 2021Yearly · 2021-12-31GeographyAmericas6,848,000,000USD0001478242-24-000038
    FY 2021Yearly · 2021-12-31GeographyAsia Pacific2,669,000,000USD0001478242-24-000038
    FY 2021Yearly · 2021-12-31GeographyEMEA4,357,000,000USD0001478242-24-000038
    FY 2021Yearly · 2021-12-31SegmentContract Sales And Medical Solutions784,000,000USD0001478242-24-000038
    FY 2021Yearly · 2021-12-31SegmentResearch And Development Solutions7,556,000,000USD0001478242-24-000038
    FY 2021Yearly · 2021-12-31SegmentTechnology And Analytics Solutions5,534,000,000USD0001478242-24-000038
    FY 2020Yearly · 2020-12-31GeographyAmericas5,419,000,000USD0001478242-23-000044
    FY 2020Yearly · 2020-12-31GeographyAsia Pacific2,245,000,000USD0001478242-23-000044
    FY 2020Yearly · 2020-12-31GeographyEMEA3,695,000,000USD0001478242-23-000044
    FY 2020Yearly · 2020-12-31SegmentContract Sales And Medical Solutions741,000,000USD0001478242-23-000044
    FY 2020Yearly · 2020-12-31SegmentResearch And Development Solutions5,760,000,000USD0001478242-23-000044
    FY 2020Yearly · 2020-12-31SegmentTechnology And Analytics Solutions4,858,000,000USD0001478242-23-000044
    FY 2019Yearly · 2019-12-31GeographyAmericas5,462,000,000USD0001478242-22-000041
    FY 2019Yearly · 2019-12-31GeographyAsia Pacific2,149,000,000USD0001478242-22-000041
    FY 2019Yearly · 2019-12-31GeographyEMEA3,477,000,000USD0001478242-22-000041
    FY 2019Yearly · 2019-12-31SegmentContract Sales And Medical Solutions814,000,000USD0001478242-22-000041
    FY 2019Yearly · 2019-12-31SegmentResearch And Development Solutions5,788,000,000USD0001478242-22-000041
    FY 2019Yearly · 2019-12-31SegmentTechnology And Analytics Solutions4,486,000,000USD0001478242-22-000041
    FY 2018Yearly · 2018-12-31GeographyAmericas4,998,000,000USD0001478242-21-000020
    FY 2018Yearly · 2018-12-31GeographyAsia Pacific1,966,000,000USD0001478242-21-000020
    FY 2018Yearly · 2018-12-31GeographyEMEA3,448,000,000USD0001478242-21-000020
    FY 2018Yearly · 2018-12-31SegmentContract Sales And Medical Solutions810,000,000USD0001478242-21-000020
    FY 2018Yearly · 2018-12-31SegmentResearch And Development Solutions5,465,000,000USD0001478242-21-000020
    FY 2018Yearly · 2018-12-31SegmentTechnology And Analytics Solutions4,137,000,000USD0001478242-21-000020

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.